Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 58.71M
March 31, 2026 58.71M
December 31, 2025 56.66M
September 30, 2025 56.54M
June 30, 2025 55.80M
March 31, 2025 55.72M
December 31, 2024 55.59M
September 30, 2024 55.59M
June 30, 2024 55.33M
March 31, 2024 42.59M
December 31, 2023 42.28M
September 30, 2023 42.22M
June 30, 2023 41.85M
Date Value
March 31, 2023 41.82M
December 31, 2022 41.80M
September 30, 2022 41.80M
June 30, 2022 41.63M
March 31, 2022 41.43M
December 31, 2021 41.30M
September 30, 2021 37.04M
June 30, 2021 36.86M
March 31, 2021 36.83M
December 31, 2020 36.79M
September 30, 2020 35.81M
June 30, 2020 35.81M
March 31, 2020 35.81M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Anavex Life Sciences Corp. 92.70M
Vaxcyte, Inc. 144.79M
Connect Biopharma Holdings Ltd. 62.97M
Caribou Biosciences, Inc. 106.00M
Arrowhead Pharmaceuticals, Inc. 141.14M